Coagulation factor Xa and thrombin (serine proteases of coagulation) (Factor Xa (FXa), Thrombin (FIIa))
Target
Factor Xa (FXa), Thrombin (FIIa)
Molecular classification
Enzyme, Serine protease (trypsin-like), Protease (EC class 3.4.21), Blood coagulation factor, Endopeptidase (for Thrombin specifically), Endopeptidase (for Factor Xa specifically)
01
Overview
Coagulation factor Xa and thrombin are central serine protease enzymes in the blood coagulation cascade. Factor Xa cleaves prothrombin to generate thrombin (activated Factor II), which then converts fibrinogen to fibrin, resulting in clot formation. These proteases possess a characteristic serine protease catalytic triad and are regulated by endogenous inhibitors (serpins) and several anticoagulant drug classes. They are tightly controlled to prevent both thrombosis and excessive bleeding. Beyond coagulation, these enzymes contribute to inflammatory signaling, vascular biology, and tissue repair. Pharmacological inhibition of factor Xa and thrombin is a mainstay for the prevention and treatment of arterial and venous thrombotic disorders.
Direct enzymatic inhibition (bind active site or exosites).
Indirect inhibition (promote inactivation by antithrombin, e.g., heparin).
Inhibition of factor synthesis (vitamin K antagonists block carboxylation of factors, rendering them inactive).
03
Biological functions
Blood coagulation (hemostasis)Conversion of fibrinogen to fibrin (via thrombin)Platelet activation (direct, thrombin)Amplification and regulation of clotting cascadeInflammatory signalingWound healing, angiogenesis, and tissue remodeling
04
Disease associations
Cardiovascular disease (thrombosis, myocardial infarction, stroke)Venous thromboembolismInflammatory disorders (including DIC, sepsis)Bleeding disorders (deficiency or dysfunction)Infection-related coagulopathiesOther: Atherosclerosis, cancer (pro-thrombotic states)
05
Safety considerations
Bleeding risk (major, clinically significant bleeding is the principal safety concern of all anticoagulants targeting these proteases)Rebound thrombosis after abrupt discontinuationDrug-drug interactions (notably with warfarin)Altered pharmacokinetics in renal/hepatic impairment (notably for some direct inhibitors)Limited reversal options for some direct inhibitors (specific antidotes now exist for some agents)Monitoring challenges (not all drugs require, or are amenable to, routine coagulation monitoring)HIT (heparin-induced thrombocytopenia; for heparin and LMWH)
06
Interacting drugs
Direct Factor Xa inhibitors: rivaroxaban, apixaban, edoxaban, betrixaban
4 more in the full profile.
07
Biomarkers
D-dimer (fibrin degradation, indirect marker)Prothrombin time (PT), International Normalized Ratio (INR, for warfarin therapy)Activated partial thromboplastin time (aPTT)Anti-FXa activity (for monitoring direct and indirect FXa inhibitors)Thrombin generation assays (research/monitoring)
Beyond the preview
Go deeper on Coagulation factor Xa and thrombin (serine proteases of coagulation) (Factor Xa (FXa), Thrombin (FIIa)).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Coagulation factor Xa and thrombin (serine proteases of coagulation) (Factor Xa (FXa), Thrombin (FIIa)).